<DOC>
	<DOC>NCT01033903</DOC>
	<brief_summary>The main objective of the study is to determine if there is a difference in the number of women with a complete miscarriage after 10 days between expectant management versus treatment with 800 micrograms of misoprostol intravaginally in women with an an incomplete miscarriage before 14 weeks and a gestational sac retained in the uterus.</brief_summary>
	<brief_title>Optimal Treatment of Miscarriage</brief_title>
	<detailed_description />
	<mesh_term>Abortion, Spontaneous</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>nonviable intrauterine pregnancy with retained gestational sac in the uterus the embryo if visible 5 to 35 mm without a heart beat vaginal bleeding circulatory stable hemoglobin at least 80 g/L contraindications against misoprostol</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Abortion, Spontaneous</keyword>
	<keyword>Randomized Controlled Trial</keyword>
</DOC>